653 Pill — WHITE CAPSULE, 13mm — Metformin

No photo available

Imprint	653
Colour	WHITE
Shape	CAPSULE
Size	13
Strength	GLYBURIDE 1.25 mg;METFORMIN HYDROCHLORIDE 250 mg
Dosage form	Tablet
Manufacturer	Zydus Pharmaceuticals (USA) Inc.
NDC	68382-653
Schedule	—
Availability	Prescription only
Ingredients	GLYBURIDE[GLYBURIDE];METFORMIN HYDROCHLORIDE[METFORMIN]

What does this imprint mean?

The imprint "653" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Metformin

Uses and warnings

BOXED WARNING - LACTIC ACIDOSIS: Postmarketing cases of metformin-associated lactic acidosis have caused death, hypothermia, hypotension, and resistant bradyarrhythmias. Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Risk factors include renal impairment, certain drug combinations, age over 65, contrast imaging procedures, surgery, hypoxic states, excessive alcohol, and hepatic impairment. If lactic acidosis is suspected, discontinue immediately and seek prompt hemodialysis. Additional Warnings: - Vitamin B12 deficiency may occur; monitor hematologic parameters annually and B12 levels every 2-3 years - Increased hypoglycemia risk when combined with insulin or insulin secretagogues - No conclusive evidence of macrovascular risk reduction

Metformin hydrochloride extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Read the full drug profile →